Editorial
No survival difference between super extended and standard lymph node dissection at radical cystectomy: what can we learn from the first prospective randomized phase III trial?
Abstract
Radical cystectomy (RC) with pelvic lymph node dissection (LND) is the standard of care local treatment for patients with muscle-invasive bladder cancer (MIBC) (≥ pT2) (1,2).
